Company Overview
Snapshot
Founded in July 2017 by Noam Hadas, Serenno Medical operates with 1-10 employees. The company has raised $2.4 million across three funding rounds from three investors. In January 2021, Elcam Medical invested in Serenno Medical to manufacture their Sentinel device, designed for kidney health monitoring.
Business overview
Serenno Medical is a Health Tech & Life Sciences company developing a novel method to monitor fluid balance and predict, identify, and avoid life-threatening complications like acute kidney injury (AKI) in intensive care unit (ICU) hospitalizations. Their core product, Sentinel, is a robust, hands-free, low-cost, and noninvasive device that provides accurate, ongoing urine output measurements. This technology enables contact-free monitoring for hospitalized, quarantined, and home ICU patients, alerting medical personnel to conditions requiring immediate attention and serving the Digital Medical Diagnostics and Medical Monitors sectors within the broader Digital Healthcare and Medical Devices markets.
Strategic signal
In January 2021, Elcam Medical invested $1.5 million in Serenno Medical to manufacture their Sentinel device, a digital monitoring solution for urine output and intra-abdominal pressure. This strategic investment and partnership indicate strong commercial validation for Serenno Medical's technology, signaling to investors a clear path towards scaling production and market penetration for their acute kidney injury detection device.
Log in to access full profile ›Company Intelligence Q&A
- What is Serenno Medical's primary focus?
- Serenno Medical focuses on developing a novel method to monitor fluid balance and predict, identify, and avoid common life-threatening complications such as acute kidney injury (AKI) in intensive care unit (ICU) hospitalizations.
- What is the Sentinel device?
- Sentinel is Serenno Medical's robust, hands-free, low-cost, and noninvasive device designed to measure accurate, ongoing urine output. It enables contact-free monitoring of hospitalized, quarantined, and home ICU patients to detect early symptoms of AKI.
- When was Serenno Medical founded?
- Serenno Medical was founded in July 2017.
- Which investors participated in Serenno Medical's January 2021 funding round?
- In January 2021, Serenno Medical received investment from Elcam Medical and Alon MedTech Ventures.